£15.25m share placing
Abcam plc, a rapidly growing company which sells antibodies to bioscientists throughout the world, has successfully raised £10 million via a placing to institutional investors. The placing is being implemented by Numis Securities ahead of the Company's admission to the AIM market of the London Stock Exchange. The placing includes £5.25m of shares from pre-existing shareholders. Dealings in Abcam shares are expected to commence on 3rd November 2005, under the ticker symbol ABC. Market capitalisation at placing price is £57.5m.
Commenting on today's announcement, Jonathan Milner, Abcam's Group Chief Executive, said: "We have been delighted by the strong demand for Abcam shares and the significant institutional support. The money raised will allow us to take advantage of future growth opportunities, enabling us to deliver our vision of building the world's largest antibody source."
For more information, please contact Buchanan Communications.
back to news list